BG
GMAB icon

Bollard Group’s Genmab GMAB Stock Holding History

Bollard Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-427
Closed -$16K – 502
2023
Q2 		$16K Buy
+427
New +$17K ﹤0.01% 265
2021
Q1 		– Sell
-200
Closed -$8K – 439
2020
Q4 		$8K Buy
+200
New +$7.48K ﹤0.01% 411
2020
Q3 		– Sell
-880
Closed -$30K – 449
2020
Q2 		$30K Buy
+880
New +$24K ﹤0.01% 387

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Bollard Group's GMAB Position: Q3 2023 in Review

Bollard Group sold out of Genmab (GMAB) in Q3 2023, closing a stake of 427 shares — an estimated $16K sold.

Bollard Group first reported a position in GMAB in Q2 2020 and held it in 3 quarters. The position peaked at $30K in Q2 2020. 233 funds tracked by Wall St. Rank hold GMAB as of Q3 2023.

  • Bollard Group reported no remaining Genmab position as of Q3 2023 after selling out during the quarter.
  • Bollard Group sold 427 Genmab shares in Q3 2023, an estimated $16K.
  • Bollard Group first reported a position in Genmab in Q2 2020 and held it in 3 quarters.
  • Bollard Group's Genmab position peaked at $30K in Q2 2020.
  • 233 funds tracked by Wall St. Rank held Genmab as of Q3 2023.

Based on Bollard Group's 13F filing for Q3 2023, filed 14 Nov 2023.